新冠肺炎合并哮喘：一例病例报告。
COVID-19 with asthma: A case report.
作者信息
Liu Ai-Ling, Xu Ning, Li Ai-Jun
机构信息
Department of Pulmonary and Critical Care Medicine, Weihai Municipal Hospital, Shandong University, Weihai 264200, Shandong Province, China.
出版信息
World J Clin Cases. 2020 Aug 6;8(15):3355-3364. doi: 10.12998/wjcc.v8.i15.3355.
BACKGROUND
Coronavirus disease 2019 (COVID-19) is a public health emergency of international concern. The global population lacks immunity to COVID-19 and is generally susceptible. Underlying conditions, especially chronic respiratory diseases, may affect progression, treatment and prognosis of COVID-19.
CASE SUMMARY
We report a patient with confirmed COVID-19 combined with asthma. It took 41 d from disease onset to discharge to obtain two negative tests for this coronavirus.
CONCLUSION
This case indicates the dynamic clinical characteristics, laboratory and computed tomography findings and adjustment of treatment, and the possible relationship between glucocorticoid therapy and coronavirus clearance.
背景
2019年冠状病毒病（COVID-19）是一项国际关注的突发公共卫生事件。全球人群对COVID-19缺乏免疫力，普遍易感。基础疾病，尤其是慢性呼吸道疾病，可能影响COVID-19的病程、治疗及预后。
病例摘要
我们报告1例确诊为COVID-19合并哮喘的患者。该患者从发病到出院共41天，两次新型冠状病毒检测均为阴性。
结论
该病例展示了其动态的临床特征、实验室及计算机断层扫描结果以及治疗调整情况，还显示了糖皮质激素治疗与新型冠状病毒清除之间可能存在的关系。
Zotero 插件